Amylyx Pharmaceuticals Inc盘中异动大幅上涨5.15%报18.56美元

自选股智能写手02-26

北京时间2024年02月26日23时06分，Amylyx Pharmaceuticals Inc（AMLX.us）股票出现异动，股价快速上涨5.15%。截至发稿，该股报18.56美元/股，成交量14.3848万股，换手率0.21%，振幅5.35%。最近的财报数据显示，该股实现营业收入3.81亿美元，净利润49.27百万美元，每股收益0.73美元，毛利3.54亿美元，市盈率26.47倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2414836499?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-02-26 23:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2414836499","market":"us","top_or_hot":-1,"title":"Amylyx Pharmaceuticals Inc盘中异动 大幅上涨5.15%报18.56美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年02月26日23时06分，Amylyx Pharmaceuticals Inc（AMLX.us）股票出现异动，股价快速上涨5.15%。截至发稿，该股报18.56美元/股，成交量14.3848万股，换手率0.21%，振幅5.35%。最近的财报数据显示，该股实现营业收入3.81亿美元，净利润49.27百万美元，每股收益0.73美元，毛利3.54亿美元，市盈率26.47倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623064987e732b5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amylyx Pharmaceuticals Inc盘中异动 大幅上涨5.15%报18.56美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmylyx Pharmaceuticals Inc盘中异动 大幅上涨5.15%报18.56美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-26 23:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623064987e732b5&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年02月26日23时06分，Amylyx Pharmaceuticals Inc（AMLX.us）股票出现异动，股价快速上涨5.15%。截至发稿，该股报18.56美元/股，成交量14.3848万股，换手率0.21%，振幅5.35%。最近的财报数据显示，该股实现营业收入3.81亿美元，净利润49.27百万美元，每股收益0.73美元，毛利3.54亿美元，市盈率26.47倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623064987e732b5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AMLX","symbol_name":"Amylyx Pharmaceuticals, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623064987e732b5&s=b","article_id":"2414836499","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623064987e732b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2414836499","pubTimestamp":1708960009,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年02月26日23时06分，Amylyx Pharmaceuticals Inc股票出现异动，股价快速上涨5.15%。截至发稿，该股报18.56美元/股，成交量14.3848万股，换手率0.21%，振幅5.35%。Amylyx Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.32%。Amylyx Pharmaceuticals Inc公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩侧索硬化症和其他神经退行性疾病的新疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AMLX":"Amylyx Pharmaceuticals, Inc.","BK4007":"制药"},"translate_title":"Amylyx Pharmaceuticals Inc. jumped 5.15 percent to $18.56 in intraday trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMLX":0.9},"content_text":"北京时间2024年02月26日23时06分，Amylyx Pharmaceuticals Inc（AMLX.us）股票出现异动，股价快速上涨5.15%。截至发稿，该股报18.56美元/股，成交量14.3848万股，换手率0.21%，振幅5.35%。最近的财报数据显示，该股实现营业收入3.81亿美元，净利润49.27百万美元，每股收益0.73美元，毛利3.54亿美元，市盈率26.47倍。机构评级方面，在所有8家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Amylyx Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Zyversa Therapeutics Inc、Apollomics Inc C/Wts 01/04/2028 (To Pur Ord)、Krystal Biotech Inc涨幅较大，Zyversa Therapeutics Inc、Lixte Biotechnology Holdings  Inc、Neubase Therapeutics Inc较为活跃，换手率分别为1231.96%、60.98%、52.79%，振幅较大的相关个股有Zyversa Therapeutics Inc、Ocean Biomedical Inc C/Wts 14/02/2028 (To Pur Com)、Calidi Biotherapeutics Inc，振幅分别为139.83%、49.55%、47.57%。Amylyx Pharmaceuticals Inc公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩侧索硬化症和其他神经退行性疾病的新疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2414836499"}

Amylyx Pharmaceuticals Inc盘中异动 大幅上涨5.15%报18.56美元

精彩评论

Amylyx Pharmaceuticals Inc盘中异动大幅上涨5.15%报18.56美元